Literature DB >> 9060907

Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

J S Gottdiener1, D J Reda, D W Williams, B J Materson.   

Abstract

OBJECTIVES: We sought to determine the relations of left atrial (LA) size to blood pressure, obesity, race, age and left ventricular (LV) mass in hypertension.
BACKGROUND: Although obesity, race and age may influence LV mass, their effects on LA size have not been defined in hypertension.
METHODS: Left atrial size was measured in 690 men (58% African-Americans) with mild to moderate hypertension (mean [+/-SD] blood pressure 152 +/- 15/98 +/- 6 mm Hg) and a high prevalence of LV hypertrophy. Effects of LV mass, adiposity, race, age, physical activity, height, weight, sodium excretion, plasma renin activity and heart rate were examined.
RESULTS: Left atrial size was greater (p < or = 0.0001) in obese (44.2 +/- 5.7 mm) than in overweight (41.6 +/- 5.9 mm) or normal weight (38.9 +/- 6.2 mm) patients. Left atrial enlargement (> or = 43 mm) was present in 56% of obese patients compared with 42% of overweight and 25% of normal weight hypertensive men. As age increased, white patients had a greater LA size than African-American patients. Although there was no relation between LV mass and LA size in normal weight patients, there was a significant positive relation in obese patients. On multiple regression analysis, obesity was the strongest independent predictor of increased LA size.
CONCLUSIONS: Obesity is the strongest predictor of LA size in patients with hypertension and amplifies the relation between LA size and LV mass. Race influences effects of age and hypertension on LA size. Because increased LA size and LV mass (also influenced by obesity) are associated with an adverse outcome, these findings underscore the importance of obesity, race and age with regard to the cardiac effects of hypertension.

Entities:  

Mesh:

Year:  1997        PMID: 9060907     DOI: 10.1016/s0735-1097(96)00554-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

Review 1.  Cardiac ultrasound imaging in heart failure: recent advances.

Authors:  Umar A Khan; Gerard P Aurigemma
Journal:  Curr Heart Fail Rep       Date:  2012-06

2.  Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index.

Authors:  Akram Khan; Faisal Latif; Beau Hawkins; Maroun Tawk; Chittur A Sivaram; Gary Kinasewitz
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

3.  Cardiac function and obesity.

Authors:  R S Vasan
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Aging and transmitral flow pattern in patients with systemic hypertension.

Authors:  Yukari Kishida; Nobuaki Tanaka; Tomoko Ezumi; Yasuyuki Hadano; Eizo Akagawa; Ryo Hashimoto; Hideki Kunichika; Kazuya Murata; Yuji Hinoda; Masunori Matsuzaki
Journal:  J Med Ultrason (2001)       Date:  2006-12-22       Impact factor: 1.314

Review 5.  The role of echocardiography in the evaluation of cardiac damage in hypertensive obese patient.

Authors:  P Crea; C Zito; M Cusmà Piccione; S Arcidiaco; M C Todaro; L Oreto; G Navarra; S Carerj
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-21

6.  Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.

Authors:  Konstantinos N Aronis; Na Wang; Caroline L Phillips; Emelia J Benjamin; Gregory M Marcus; Anne B Newman; Nicolas Rodondi; Suzanne Satterfield; Tamara B Harris; Jared W Magnani
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

7.  The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients.

Authors:  Tao Wang; Yun-Long Xia; Shu-Long Zhang; Lian-Jun Gao; Ze-Zhou Xie; Yan-Zong Yang; Jie Zhao
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

8.  Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

Authors:  Wolfgang Lieb; Ralf A Benndorf; Emelia J Benjamin; Lisa M Sullivan; Renke Maas; Vanessa Xanthakis; Edzard Schwedhelm; Jayashri Aragam; Friedrich Schulze; Rainer H Böger; Ramachandran S Vasan
Journal:  Atherosclerosis       Date:  2008-08-28       Impact factor: 5.162

Review 9.  Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

Authors:  Taher Mandviwala; Umair Khalid; Anita Deswal
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

10.  CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.